Cagrisema

from $190.00

This research peptide kit includes 10 sterile vials of the listed compound, packaged together for laboratory and research use.


Size:

This research peptide kit includes 10 sterile vials of the listed compound, packaged together for laboratory and research use.


The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.

Cagrisema is a research peptide formulation combining cagrilintide and semaglutide analogs. Experimental studies commonly investigate its interaction with incretin-related signaling pathways and metabolic regulatory systems.